Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Bank of America Corp DE

Bank of America Corp DE lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 57.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 187,819 shares of the company’s stock after selling 258,736 shares during the period. Bank of America Corp DE’s holdings in Henry Schein were worth $12,997,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HSIC. Barclays PLC grew its holdings in Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company’s stock worth $20,882,000 after acquiring an additional 18,458 shares during the period. Fifth Third Bancorp grew its holdings in Henry Schein by 11.0% during the fourth quarter. Fifth Third Bancorp now owns 3,366 shares of the company’s stock worth $233,000 after acquiring an additional 333 shares during the period. Olstein Capital Management L.P. grew its holdings in Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares during the period. Robeco Institutional Asset Management B.V. acquired a new position in Henry Schein during the fourth quarter worth $763,000. Finally, Cibc World Market Inc. grew its holdings in Henry Schein by 2.8% during the fourth quarter. Cibc World Market Inc. now owns 360,018 shares of the company’s stock worth $24,913,000 after acquiring an additional 9,954 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a report on Wednesday, April 30th. Wall Street Zen lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Finally, Barrington Research lowered their target price on Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $79.30.

Henry Schein Stock Down 1.0%

HSIC opened at $71.33 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.68 billion, a P/E ratio of 29.35, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The business’s fifty day simple moving average is $67.46 and its 200 day simple moving average is $71.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter last year, the company earned $1.10 earnings per share. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.